This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adinoff, A. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Adinoff, A. D.

PEDIATRICS Vol. 104 No. 2 Supplement August 1999, pp. 385-385

beta -Adrenergic Agonist Therapy
Comparison of Two Dosage Regimens of Albuterol in Acute Asthma

McFadden ER Jr, Strauss L, Hejal R, Galan G, Dixon L Am J Med. 1998; 105:12-17 [Medline]

The first 20% of the full text of this article appears below.

Purpose of the Study The standard therapy for acute episodes of asthma in the United States consists of three 2.5-mg doses of aerosolized albuterol given every 20 minutes. Whether this approach represents optimum therapy has never been tested.

Study Population and Methods This study used a prospective, sequential design in which the effects of two doses of 5.0 mg of aerosolized albuterol administered during 40 minutes (high-dose) . . . [Full Text of this Article]